ChatGPT Image Jan 27, 2026, 03_59_01 PM

Our Translational Research Platform for Metabolic Disease

SBH SCIENCESMetabolic Disease Research Center

We partner with industry and academic institutions to support drug development across a broad range of metabolic disorders and MASH by providing comprehensive disease modeling state-of-the-art functional assays, and biomarker discovery and development services.

 

Our In-Vitro Models, Biomarker Platforms, and Functional Assays

We have developed a platform of functional assays in a growing range of in vitro models to support drug development programs for key indications in metabolic disease drug development including:

  • Insulin Resistance & Type 2 Diabetes
  • Obesity & Adipose Dysfunction
  • Metabolic Syndrome
  • MASH/MASLD
  • Advanced MASH & Fibrosis
ChatGPT Image Jan 27, 2026, 04_27_53 PM
Biomarker Indication
IGF-1 Insulin Resistance & Glycemic Control
Adiponectin Adipose Dysfunction
Leptin Adipose Dysfunction
hsCRP Systemic Inflammation
IL-6 Systemic Inflammation
TNF-α Systemic Inflammation
CK-18 (M30/M65) Hepatocyte Injury/ Apoptosis
PIIINP Fibrosis & ECM Remodeling
sCD163 Hepatic Inflammation
Galectin-3

Hepatic Inflammation/Fibrosis

FGF21 Metabolic Stress Hormone
MMP-2/MMP-9 Fibrosis and Remodeling